Landscapes / Companies
iOnctura not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
4 active
6 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
PI3K inhibitor |
Phase 2 | Jan 2027Phase 1/2 trial completes | |||
| How it works | Blocks PI3K | ||||
| Next date | Jan 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Uveal Melanoma, Solid Tumor, Adult and 7 more | ||||
| Open drug page | |||||
About
- No active trial
- IOA-289
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021